Literature DB >> 6256552

Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.

A M Triggle, E Shefter, D J Triggle.   

Abstract

The crystal structures of 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-nitrophenyl)-1,4-dihydropyridine (Nifedipine) and the 3-cyano-, 4-(dimethylamino)- and 2,3,4,5,6-pentafluorophenyl derivatives were determined. The 1,4-dihydropyridine ring in all four compounds has a boat-type conformation with varying degrees of puckering at the C4 position. Increasing distortion from planarity at this position shows a limited correlation with decreasing biological activity, determined as the ability to inhibit the Ca2+-dependent muscarinic-induced mechanical responses of guinea pig ileal longitudinal smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6256552     DOI: 10.1021/jm00186a029

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.

Authors:  D A Langs; Y W Kwon; P D Strong; D J Triggle
Journal:  J Comput Aided Mol Des       Date:  1991-04       Impact factor: 3.686

2.  Nanomechanical properties of selected single pharmaceutical crystals as a predictor of their bulk behaviour.

Authors:  Mateja Egart; Biljana Janković; Nina Lah; Ilija Ilić; Stanko Srčič
Journal:  Pharm Res       Date:  2014-08-05       Impact factor: 4.200

3.  Complexation of nifedipine with substituted phenolic ligands.

Authors:  K M Boje; M Sak; H L Fung
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

4.  A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers.

Authors:  Xiaolin Charlie Tang; Michael J Pikal; Lynne S Taylor
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

5.  Comparative molecular modelling study of the calcium channel blockers nifedipine and black mamba toxin FS2.

Authors:  K J Schleifer
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

6.  Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.

Authors:  D A Langs; P D Strong; D J Triggle
Journal:  J Comput Aided Mol Des       Date:  1990-09       Impact factor: 3.686

7.  Diethyl 4-[4-(dimethyl-amino)phen-yl]-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxyl-ate.

Authors:  Xiao-Ling Ji; Wang-Bin Sun; Qian Zhang; Yan-Ping Cao; Ming-Sheng Bai
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-06

8.  3,5-Bis(ethoxy-carbon-yl)-2,6-dimethyl-1,4-dihydro-pyridine-4-carboxylic acid.

Authors:  De-Hong Wu; Ling Hu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-04

9.  Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state.

Authors:  F Hirayama; Z Wang; K Uekama
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

10.  A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.

Authors:  G Zernig; H Glossmann
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.